Erratum to: Cisplatin-induced mesenchymal stromal cells-mediated mechanism contributing to decreased antitumor effect in breast cancer cells
© Skolekova et al. 2016
Received: 18 February 2016
Accepted: 18 February 2016
Published: 25 February 2016
The original article was published in Cell Communication and Signaling 2016 14:4
Unfortunately, after publication of this article  it was noticed that 2 authors were not listed. The corrected author list can be seen above and the corrected Authors’ Contributions and Acknowledgements sections are included below.
We thank M. Dubrovcakova, V. Frivalska for the excellent technical assistance and B. Smolková, PhD. for help with statistic analysis. We thank L. Skirkova for technical help with vector preparation. This study was supported by the VEGA grants No.2/0087/15 (L.K.) and 2/0171/13 (M.M.). This work was supported by the Slovak Research and Development Agency under the contract No.APVV-0230-11 and No.APVV-0052-12. The experiments on the IncuCyte ZOOM™ were enabled with the kind help and the financial support from the Cancer Research Foundation.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Skolekova S, Matuskova M, Bohac M, Toro L, Demkova L, Gursky J, Kucerova L. Cisplatin-induced mesenchymal stromal cells-mediated mechanism contributing to decreased antitumor effect in breast cancer cells. Cell Commun Signal. 2016;14:4.Google Scholar